Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Princeton, New Jersey
- Most recent report
- 8-K, filed Aug 24, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1023024
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 49
News 8 of 201
- 8-K Leadership change Aug 24, 2026
- 8-K Quarterly results Aug 7, 2026
- 8-K Leadership change May 21, 2026
- 8-K Current report on a material event May 13, 2026
- 8-K Quarterly results May 8, 2026
- 8-K Current report on a material event Apr 7, 2026
- 8-K Current report on a material event Mar 3, 2026
- 8-K Quarterly results Feb 27, 2026
Prospectuses and Registrations 8 of 22
- S-8 Registration statement for an employee plan Jul 17, 2026
- S-8 Registration statement for an employee plan Jul 11, 2025
- S-8 Registration statement for an employee plan Jul 11, 2025
- S-8 Registration statement for an employee plan Jul 12, 2024
- S-8 Registration statement for an employee plan Jun 23, 2023
- 424B5 Prospectus supplement for an offering May 12, 2023
- 424B5 Prospectus supplement for an offering May 11, 2023
- S-8 Registration statement for an employee plan Apr 27, 2022
Proxies 8 of 28
- DEFA14A Extra proxy material Apr 9, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 9, 2026
- DEFA14A Extra proxy material May 8, 2025
- DEFA14A Extra proxy material Apr 10, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2025
- PRE 14A Preliminary proxy statement Mar 31, 2025
- DEFA14A Extra proxy material Apr 5, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 5, 2024
Ownership 8 of 652
- 4 Insider reported a trade Sep 1, 2026
- 4 Insider reported a trade Aug 27, 2026
- 3 Insider reported their initial holding Aug 27, 2026
- 4 Insider reported a trade Aug 26, 2026
- 144 Notice of a proposed sale of restricted stock Aug 25, 2026
- 4 Insider reported a trade Aug 13, 2026
- 4 Insider reported a trade Aug 11, 2026
- 4 Insider reported a trade Jul 30, 2026
Other 8 of 48
- ARS Annual report sent to shareholders Apr 9, 2026
- ARS Annual report sent to shareholders Apr 10, 2025
- ARS Annual report sent to shareholders Apr 5, 2024
- ARS Annual report sent to shareholders Apr 11, 2023
- CT ORDER Feb 22, 2023
- UPLOAD Comment letter from SEC staff Jan 30, 2023
- CORRESP Reply to SEC staff Jan 27, 2023
- CORRESP Reply to SEC staff Jan 6, 2023
Everything here comes from Ani Pharmaceuticals Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.